The UK’s referendum decision to leave the EU in May 2016 undoubtedly sent shockwaves throughout Europe. European countries are still struggling to interpret what ‘Brexit’ will mean for them. Ireland,
Tag "brexit"
![European Medicines Agency fears losing staff after it leaves London](http://www.biopharmabusiness.com/wp-content/uploads/2017/10/EMA-505x306_c.jpg)
Losing valuable staff is the major concern in the impending relocation of the European Medicines Agency. The agency which is responsible for the evaluation, authorisation and pharmacovigilance of all medicines
![British manufacturing industry calls on government to rethink Brexit strategy](http://www.biopharmabusiness.com/wp-content/uploads/2017/06/EEF-Brexit-505x306_c.jpg)
British manufacturers are asking the government to negotiate access to the single market and a form of customs union along with suitable transition period. The call comes from EEF, the
![Expats returning post Brexit could cost NHS £500m](http://www.biopharmabusiness.com/wp-content/uploads/2017/06/ThinkstockPhotos-451078229-505x306_c.jpg)
The NHS could be faced with having to pay nearly half a billion pounds more if British expats decide to return to the UK because their right to healthcare in
![NHS could lose more than 2,000 GPs through Brexit](http://www.biopharmabusiness.com/wp-content/uploads/2017/05/brexit_whats_next-505x306_c.jpg)
GP leaders are warning that nearly 3.5 million patients are at risk of losing their family doctor, if the status of doctors from the European Union is not protected during
![European countries offer goodies in bid to win EMA after Brexit](http://www.biopharmabusiness.com/wp-content/uploads/2017/05/EUFlag1-505x306_c.jpg)
Even before European officials present the groundwork for relocating the bloc’s drug regulator, a fight has emerged between countries vying for the economic lift and status that come with hosting the
![Ireland reiterates bid to host the European Medicines Agency post-Brexit](http://www.biopharmabusiness.com/wp-content/uploads/2017/05/ireland-medicine-410x246-505x306_c.jpg)
Ireland has stepped up its bid to host the European Medicines Agency (EMA) with the official announcement being delivered and reiterated by Minister of Health, Simon Harris over the past
On May 2, 2017, the EMA and European Commission published a notice alerting Marketing Authorization Holders of centrally authorized medicines of their obligations in relation to Brexit. Although the final
With Brexit centre stage, there is a temptation for all attention in Ireland to focus on two topics: how much the move might damage our economy; and what opportunity it
Now that the die has been cast, it’s time for the deal-making process to begin – if indeed a deal is on the cards. It seems that every time a
The move by Great Britain to step away from the European Union may be sending chills of uncertainty to many businesses in the United Kingdom, but to at least one
Frost & Sullivan, Gary Jeffery comments on the implications of Brexit for businesses both in and out of the UK. Theresa May set out an ambitious plan of maintaining a
In an editorial published in the journal ecancermedicalscience, leading academics from across the UK explore the risks facing cancer care, treatment and research in a post-Brexit world. The editorial is